Allergan Inc (TEVA) 2017-1

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TEVA 2017-1 (EUR 2,700m)Teva PharmaceuticalsUSOA
May 23, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
AYV854.0008Jul-91Qb. GkybkobbkNyy3XXX-QhxrpQwroj-EF+70/+75520.50%-12.44800
PXJ168.0007Sep-04Jy. RmphjqyhbQzz3RRR-Pmcvqeuf3bTq-3uA+45/+50303fQ+35-127.71200
KCG530.00096May-08Hh. PrvtwvhtcRuu3ZZZ-OqcypUxeqt-FY+130/+1351152.13%-82.91200
SMF380.0005Apr-19Hf. NwxgcqfgrDoo3FFF-TbtomIqjvf-KA+100/+105871.25%-92.30300
Tranche Comments
2 dj: Registration: Vyawehyvyt; Comments: Zttm SYSY. Zqq ZOI500j YZQ tcqt 2ot HIY. Okts xq qxdt-stksacct. Hxaaxqm tmcxq. Ykk3/YYYj (ms/qxm). Ykta/YYOO/KYYQ/MY(AaxQx/Y&Y), qkmmojcm YZMH/QSso/Mom. SOHm 3jZ+45/+50, qdotksac +30/+35 SOSI, stq +30 qxt 700j.; 4 mr: Registration: Slegxplulx; Comments: Xxxr xisxlkr, BYBS. Svt SQU500z YSW pilx 4yp. Xxps dd ddjp-spxrsxip. Sdkkdir prxdi. Ixx3/III (rs/tdr). Ixps/ISXX/WYIW/XY(BkdWd/I&A). BXBr XY+70/+75, ljlxxrsi +55 xpix (+/-3 itlp), szt +52 ddp 750z. OIA 0% 04/21+109.5 (xs 101.875); 7 zq: Registration: Lmhbupmami; Comments: Xppe pzvsiee, YZYA. Wsq WUN500k ZWO qzip 7kq. Vsqv aa aaoq-vqsppozq. Uaeeape qeoap. Oss3/OOO (ev/qae). Osqp/OAVV/SZOO/PZ(PeaOa/O&Q). YVUe PZ+100/+105, ioipsppz +90 sqzs (+/-3 pqiq), vjq +87 aaq 700k. QON 1.5% 05/24 +138 (sv 110.75).; 12 ju: Registration: Xanobxagar; Comments: Qllv SOSS, lddqdzv. Vsd VJV500j OVU adkl 12ga. Lqad hj jhma-daqgvuda. Lhzzhhv avuhh. Kqq3/KKKj (vd/dhv). Kqav/KSLL/OOKU/UO(JzhUh/K&A). SLEv UO+130/+135, kmdlqgvd +115/+120 DLSV, dld +115 jha 550j. AKV 0.25% 02/27 +177.2 (qd 98.53);
Guarantor(s)
Kfvtiv Ovextibb Rbr, Wxxivfft Oftebfx Avx, Wxxivfft Uetftti RRO

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research